Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shi-Ying Cai

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Biorxiv : the Preprint Server for Biology|January 27, 2025
Liver Lymphatic Dysfunction as a Driver of Fibrosis and Cirrhosis ProgressionJain Jeong, Shao-Jung Hsu, Daiki Horikami, et al.
Acta Pharmacologica Sinica|December 22, 2018
A novel ASBT inhibitor, IMB17-15, repressed nonalcoholic fatty liver disease development in high-fat diet-fed Syrian golden hamstersMao-Xu Ge, Wei-Xiao Niu, Jin-Feng Ren, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 9, 2006
Hepatic and extrahepatic synthesis and disposition of dinitrophenyl-S-glutathione in bile duct-ligated ratsSilvina S M Villanueva, María L Ruiz, Carol J Soroka, et al.
Cellular and Molecular Gastroenterology and Hepatology|May 5, 2023
Organic Anion Transporting Polypeptide (OATP) 1B3 is a Significant Transporter for Hepatic Uptake of Conjugated Bile Acids in HumansQiong Pan, Guanyu Zhu, Ziqian Xu, et al.
Gastroenterology|August 1, 2018
Solute Carrier Organic Anion Transporter Family Member 3A1 Is a Bile Acid Efflux Transporter in CholestasisQiong Pan, Xiaoxun Zhang, Liangjun Zhang, et al.
Hepatology (Baltimore, Md.)|January 17, 2023
Runt-related transcription factor-1 ameliorates bile acid-induced hepatic inflammation in cholestasis through JAK/STAT3 signalingLiangjun Zhang, Qiong Pan, Lu Zhang, et al.
Hepatology (Baltimore, Md.)|July 10, 2024
Hepatic GDP-fucose transporter SLC35C1 attenuates cholestatic liver injury and inflammation by inducing CEACAM1 N153 fucosylationLiangjun Zhang, Pingfan Xie, Mingqiao Li, et al.
JCI Insight|August 8, 2022
SEMA7AR148W mutation promotes lipid accumulation and NAFLD progression via increased localization on the hepatocyte surfaceNan Zhao, Xiaoxun Zhang, Jingjing Ding, et al.
EMBO Molecular Medicine|September 29, 2021
A homozygous R148W mutation in Semaphorin 7A causes progressive familial intrahepatic cholestasisQiong Pan, Gang Luo, Jiaquan Qu, et al.
Cell Metabolism|February 8, 2018
Digoxin Suppresses Pyruvate Kinase M2-Promoted HIF-1α Transactivation in SteatohepatitisXinshou Ouyang, Sheng-Na Han, Ji-Yuan Zhang, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Biorxiv : the Preprint Server for Biology|January 27, 2025
Liver Lymphatic Dysfunction as a Driver of Fibrosis and Cirrhosis ProgressionJain Jeong, Shao-Jung Hsu, Daiki Horikami, et al.
Acta Pharmacologica Sinica|December 22, 2018
A novel ASBT inhibitor, IMB17-15, repressed nonalcoholic fatty liver disease development in high-fat diet-fed Syrian golden hamstersMao-Xu Ge, Wei-Xiao Niu, Jin-Feng Ren, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 9, 2006
Hepatic and extrahepatic synthesis and disposition of dinitrophenyl-S-glutathione in bile duct-ligated ratsSilvina S M Villanueva, María L Ruiz, Carol J Soroka, et al.
Cellular and Molecular Gastroenterology and Hepatology|May 5, 2023
Organic Anion Transporting Polypeptide (OATP) 1B3 is a Significant Transporter for Hepatic Uptake of Conjugated Bile Acids in HumansQiong Pan, Guanyu Zhu, Ziqian Xu, et al.
Gastroenterology|August 1, 2018
Solute Carrier Organic Anion Transporter Family Member 3A1 Is a Bile Acid Efflux Transporter in CholestasisQiong Pan, Xiaoxun Zhang, Liangjun Zhang, et al.
Hepatology (Baltimore, Md.)|January 17, 2023
Runt-related transcription factor-1 ameliorates bile acid-induced hepatic inflammation in cholestasis through JAK/STAT3 signalingLiangjun Zhang, Qiong Pan, Lu Zhang, et al.
Hepatology (Baltimore, Md.)|July 10, 2024
Hepatic GDP-fucose transporter SLC35C1 attenuates cholestatic liver injury and inflammation by inducing CEACAM1 N153 fucosylationLiangjun Zhang, Pingfan Xie, Mingqiao Li, et al.
JCI Insight|August 8, 2022
SEMA7AR148W mutation promotes lipid accumulation and NAFLD progression via increased localization on the hepatocyte surfaceNan Zhao, Xiaoxun Zhang, Jingjing Ding, et al.
EMBO Molecular Medicine|September 29, 2021
A homozygous R148W mutation in Semaphorin 7A causes progressive familial intrahepatic cholestasisQiong Pan, Gang Luo, Jiaquan Qu, et al.
Cell Metabolism|February 8, 2018
Digoxin Suppresses Pyruvate Kinase M2-Promoted HIF-1α Transactivation in SteatohepatitisXinshou Ouyang, Sheng-Na Han, Ji-Yuan Zhang, et al.
Pageof 6